PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines? C. Guijarro; M. Camafort;

Clinical characteristics of premature cardiovascular disease in our health area M. Viscasillas; I. Lamíquiz-Moneo; M.R. Pérez-Ruiz; R. Garcia-Fenoll; E. Jarauta;

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus V. Barrios; P. Beato; C. Brotons; R. Campuzano; J.F. Merino-Torres; J.M. Mostaza; N. Plana; J.A. Rubio; M. Comellas;